Intuitive Surgical, Inc. (ISRG)

Healthcare
Medical Instruments & Supplies
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$495.15
▲ 2.31 (0.47%)
Market Cap
$175,842,738,176
Shares: 359,575,000
P/E
N/A
P/B: N/A
ROE
16.03%
Current Ratio: 4.87
Fundamentals Score
83 (POSITIVE)

Company Overview

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Headquarters: 1020 Kifer Road, Sunnyvale, CA, 94086-5304, United States  |  Employees: 17021  |  Website: intuitive.com
Key Contacts
IR / Phone: 408 523 2100
Exchange: NMS
Industry: Medical Instruments & Supplies
Quick Financial Snapshot
Revenue$10,064,700,000
Net Income$2,876,600,000
Free Cash Flow$3,696,300,000
Book Value / ShareN/A

Balance Sheet & Liquidity

Total Liabilities$2,517,000,000
Total Equity$17,941,700,000
Debt / EquityN/A
Current Ratio4.87
Interest CoverageN/A
Working CapitalN/A

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)N/A
Industry P/EN/A
Forward P/E43.31
P/BN/A
Price / SalesN/A
P / FCFN/A
EV / EBITDAN/A
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 66.00%
Operating Margin N/A
Net Margin N/A
ROIC N/A
Asset Turnover N/A

Automated Fundamental Signals (Score: 83)

Passed
  • EPS shows upward trend
  • EPS CAGR 42.32%
  • Price CAGR 21.53%
  • Gross Margin 66.0%
  • Debt/Equity ratio
  • Operating Margin 29.3%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
Failed
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 65)

RSI (14)34.79
SMA 50547.25
SMA 200516.39
MACD-18.92
Signal NEUTRAL
RSI 34.8, SMA trend bullish, momentum -16.9%.

Governance & Management

Governance scores: Audit: 1 | Board: 6 | Compensation: 5 | Shareholder Rights: 4
Executive Team
NameTitle
Dr. Gary S. Guthart Ph.D. Executive Chair (1966)
Mr. David J. Rosa CEO & Director (1968)
Mr. Jamie E. Samath Executive VP, CFO, Head of Business Technology & Enterprise Technology Leader (1971)
Mr. Henry L. Charlton Executive VP and Chief Commercial & Marketing Officer (1970)
Dr. Brian E. Miller Ph.D. Head of Digital & AI Strategy (1976)
Mr. Fredrik Widman VP, Principal Accounting Officer & Corporate Controller (—)
Mr. Milind Wagle Chief Information Officer (—)
Mr. Daniel P. Connally C.F.A. VP & Head of Investor Relations (—)
Governance data last updated: 2/1/2026

Latest News

No news available for this company.

← Back